Schedule & Agenda

Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.








A new report on industry clinical success rates will be released at BIO CEO 2021. Join the…

In less than a decade, CRISPR has moved from breakthrough scientific paper to a Nobel Prize,…

Both U.S. political parties have proposed changes to the reimbursement process for FDA-approved…


Click Join Online below to enter the Networking Event.
Join for live interaction with a…




3T Biosciences is an immunotherapy company based in South San Francisco. The…














































ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based…






















Leading BioSciences is developing novel therapeutics designed to improve human health through…










Most drug candidates (>70%) are poorly soluble resulting in poor bioavailability. Many…




























Retrotope is a clinical-stage biopharmaceutical company focused on the development of first-in…



Rubedo mission is to extend health-span by making novel targeted drugs customized for the…

























XORTX Therapeutics Inc. is a biopharmaceutical company focused on developing therapies to treat…
